Cambridge Investment Research Advisors
NXGN

Cambridge Investment Research Advisors’s NextGen Healthcare, Inc. Common Stock NXGN Stock Holding History

Cambridge Investment Research Advisors’s Portfolio NXGN Stock Details NXGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-39,266
Closed -$788K – 2308
2018
Q3 		$788K Buy
+39,266
New +$832K 0.01% 1171
2017
Q4 		– Sell
-36,053
Closed -$567K – 2172
2017
Q3 		$567K Buy
+36,053
New +$582K 0.01% 1186

Other funds holding NXGN

BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ICOM
Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cambridge Investment Research Advisors's NXGN Position: Q4 2018 in Review

Cambridge Investment Research Advisors sold out of NextGen Healthcare, Inc. Common Stock (NXGN) in Q4 2018, closing a stake of 39,266 shares — an estimated $788K sold.

Cambridge Investment Research Advisors first reported a position in NXGN in Q3 2017 and held it in 2 quarters. The position peaked at $788K in Q3 2018. 175 funds tracked by Wall St. Rank hold NXGN as of Q4 2018.

  • Cambridge Investment Research Advisors reported no remaining NextGen Healthcare, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 39,266 NextGen Healthcare, Inc. Common Stock shares in Q4 2018, an estimated $788K.
  • Cambridge Investment Research Advisors first reported a position in NextGen Healthcare, Inc. Common Stock in Q3 2017 and held it in 2 quarters.
  • Cambridge Investment Research Advisors's NextGen Healthcare, Inc. Common Stock position peaked at $788K in Q3 2018.
  • 175 funds tracked by Wall St. Rank held NextGen Healthcare, Inc. Common Stock as of Q4 2018.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2018, filed 5 Feb 2019.